All In Biotech

Drug Trial Radar · NCT05331183

Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del

A Phase 3 Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

297

Actual

Start

Nov 23, 2022

Primary completion

Apr 6, 2027

Study completion Apr 6, 2027

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Apr 15, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long-term safety, efficacy and pharmacodynamics of ELX/TEZ/IVA in participants with cystic fibrosis (CF) with at least 1 non-F508del ELX/TEZ/IVA-responsive CF transmembrane conductance regulator (CFTR) gene mutation.

Conditions

  • Cystic Fibrosis

Interventions

  • ELX/TEZ/IVADrug

    Fixed-dose combination (FDC) tablets for oral administration.

  • IVADrug

    Tablets for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Parts A and B: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Day 1 up to Week 196

Locations

81 sites in 15 countries. Site status is shown where the registry gives one.

  • Medizinische Universität Innsbruck - Heilstättenschule Universitätsklinik

    Innsbruck, Austria

  • CUB Hôpital Erasme

    Brussels, Belgium

  • UZ Brussel - Campus Jette

    Brussels, Belgium

  • Universitair Ziekenhuis Antwerpen (UZA) - Antwerp University Hospital

    Edegem, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

    Leuven, Belgium

  • Universite Catholique de Louvain - Pulmonology

    Woluwe-Saint-Lambert, Belgium

  • Stollery Children's Hospital

    Edmonton, Canada

  • Le Centre de recherche du CHUM (CRCHUM)

    Montreal, Canada

  • McGill University Health Centre, Glen Site, Montreal Children's Hospital

    Montreal, Canada

  • Hospital for Sick Children - Pulmonology

    Toronto, Canada

  • British Columbia Children's Hospital

    Vancouver, Canada

  • St. Paul's Hospital - Pulmonology

    Vancouver, Canada

  • Klinika Detskych Infekcnich Nemoci

    Brno, Czechia

  • Motol University Hospital

    Prague, Czechia

  • Hopital Femme Mere-Enfant

    Bron, France

  • Centre Hospitalier Intercommunal Creteil - Pulmonology

    Créteil, France

  • Institut Cœur Poumon, CHU de Lille

    Lille, France

  • Hopital Nord

    Marseille, France

  • Hopital Arnaud de Villeneuve - Service de Pneumologie et Maladies Respiratoires

    Montpellier, France

  • Hôpital Nord Laennec

    Nantes, France

  • CHU de Nice - Hôpital Pasteur 2

    Nice, France

  • Hopital Cochin - Pulmonology

    Paris, France

  • Hopital Necker Enfants Malades - Pulmonology

    Paris, France

  • Hopital Robert Debre - Pulmonology

    Paris, France

  • Hôpital Lyon Sud - Pulmonology

    Pierre-Bénite, France

  • Hôpital américain de Reims - Département de pédiatrie A

    Reims, France

  • Hôpital Sud - Rennes

    Rennes, France

  • Centre de Perharidy, Roscoff

    Roscoff, France

  • Hopital Larrey

    Toulouse, France

  • Hopital Bretonneau

    Tours, France

  • Charité - Paediatric Pulmonology Department

    Berlin, Germany

  • University Hospital Cologne (Koeln) - CF-Studienzentrum

    Cologne, Germany

  • Ruhrlandklinik

    Essen, Germany

  • Klinikum der Johann-Wolfgang-Goethe Universitaet - Pulmonology

    Frankfurt, Germany

  • Justus-Liebig-Universität Gießen

    Giessen, Germany

  • Universitätsklinikum Halle (Saale) / Universitätsklinik und Poliklinik für Innere Medizin, Schwerpunkt Pneumologie

    Halle, Germany

  • Medizinische Hochschule Hannover - Clinic for Pediatric Pneumology, Allergology and Neonatology, CF-Centre

    Hanover, Germany

  • Medizinische Hochschule Hannover

    Hanover, Germany

  • Mukoviszidose-Zentrum am Universitätsklinikum Jena

    Jena, Germany

Showing 40 of 81 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.